Company Description
NeuroOne Medical Technologies Corporation operates as a medical technology company.
The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.
It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode.
The company is based in Eden Prairie, Minnesota.
| Country | United States |
| IPO Date | Mar 15, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 16 |
| CEO | David A. Rosa M.D. |
Contact Details
Address: 7599 Anagram Drive Eden Prairie, Minnesota United States | |
| Website | https://n1mtc.com |
Stock Details
| Ticker Symbol | NMTC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001500198 |
| CUSIP Number | 64130M209 |
| ISIN Number | US64130M2098 |
| Employer ID | 27-0863354 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Rosa M.D. | President, Chief Executive Officer & Director |
| Christopher R. Volker CFA | Chief Operating Officer |
| Ronald W. McClurg | Chief Financial Officer |
| Steven Mertens | Chief Technology Officer |
| Hijaz Haris | Vice President of Marketing |
| Mark Christianson | Co-Founder, Business Development Director & Medical Sales Liaison |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 03, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Nov 25, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 08, 2024 | 8-K | Current Report |
| Nov 01, 2024 | 4 | Filing |
| Nov 01, 2024 | 4 | Filing |
| Nov 01, 2024 | 4 | Filing |